A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Vitamin- Mineral Omega-3 Supplement (Concept DHA)

Vitamin- Mineral Omega-3 Supplement supplements vitamin C (ascorbic acid).

First FDA approval2009-06-24
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$1.06/unit
1 NDCs benchmarked, lowest of all strengths.
Average NADAC
$1.06
Across all dosage forms in distribution.
Highest NADAC
$1.06
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema8 entries indexed · 4 visible
What is Vitamin- Mineral Omega-3 Supplement used for?

Vitamin- Mineral Omega-3 Supplement supplements vitamin C (ascorbic acid).

Is there a generic for Vitamin- Mineral Omega-3 Supplement?

No. Vitamin- Mineral Omega-3 Supplement is brand-only with no generic equivalents currently in market.

How much does my plan pay for Vitamin- Mineral Omega-3 Supplement?

Across 329 Part D plans, Vitamin- Mineral Omega-3 Supplement averages $1.06/unit (NADAC). Lowest available: $1.06/unit. Highest in distribution: $1.06/unit.

Is Vitamin- Mineral Omega-3 Supplement on the FDA shortage list?

No. Vitamin- Mineral Omega-3 Supplement is not currently on the FDA Drug Shortage Database.

4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.